Variant report

Variant	nsv4064
Chromosome Location	chr3:151298187-151370986
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:298)
CpG islands
(count:61)
Chromatin interactive
region (count:34)
LncRNA
region (count:4)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:298 , 50 per page) page: 1 2 3 4 5 6

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr3:151348946-151349428	HepG2	liver:	n/a	n/a
2	ARID3A	chr3:151347854-151348216	HepG2	liver:	n/a	n/a
3	ATF1	chr3:151348858-151349258	K562	blood:	n/a	n/a
4	ATF3	chr3:151348870-151349261	K562	blood:	n/a	n/a
5	BACH1	chr3:151316663-151316749	K562	blood:	n/a	n/a
6	BATF	chr3:151302504-151302757	GM12878	blood:	n/a	chr3:151302639-151302650
7	BATF	chr3:151302506-151302736	GM12878	blood:	n/a	chr3:151302639-151302650
8	BHLHE40	chr3:151348864-151349279	HepG2	liver:	n/a	n/a
9	BHLHE40	chr3:151298954-151299093	GM12878	blood:	n/a	n/a
10	BHLHE40	chr3:151316356-151316382	A549	lung:	n/a	n/a
11	BHLHE40	chr3:151348807-151349218	K562	blood:	n/a	n/a
12	BHLHE40	chr3:151356924-151357164	K562	blood:	n/a	n/a
13	BHLHE40	chr3:151356898-151357272	HepG2	liver:	n/a	n/a
14	CBX3	chr3:151305418-151305806	K562	blood:	n/a	n/a
15	CBX3	chr3:151344442-151344768	K562	blood:	n/a	n/a
16	CBX3	chr3:151348795-151349198	K562	blood:	n/a	n/a
17	CCNT2	chr3:151320390-151320571	K562	blood:	n/a	n/a
18	CEBPB	chr3:151348785-151349336	K562	blood:	n/a	chr3:151349066-151349077
19	CEBPB	chr3:151348870-151349268	K562	blood:	n/a	chr3:151349066-151349077
20	CEBPB	chr3:151348930-151349221	Hela-S3	cervix:	n/a	chr3:151349066-151349077
21	CEBPB	chr3:151312087-151312178	K562	blood:	n/a	n/a
22	CEBPB	chr3:151298368-151298727	ECC-1	luminal epithelium:	n/a	chr3:151298600-151298611 chr3:151298600-151298611 chr3:151298575-151298592
23	CEBPB	chr3:151348765-151349289	MCF-7	breast:	n/a	chr3:151349066-151349077
24	CEBPB	chr3:151298555-151298655	H1-hESC	embryonic stem cell:	n/a	chr3:151298600-151298611 chr3:151298600-151298611 chr3:151298575-151298592
25	CEBPB	chr3:151309997-151310398	H1-hESC	embryonic stem cell:	n/a	n/a
26	CEBPB	chr3:151314683-151314814	HepG2	liver:	n/a	n/a
27	CEBPB	chr3:151349813-151349872	Hela-S3	cervix:	n/a	n/a
28	CEBPB	chr3:151348803-151349308	MCF-7	breast:	n/a	chr3:151349066-151349077
29	CEBPB	chr3:151348986-151349153	HepG2	liver:	n/a	chr3:151349066-151349077
30	CEBPB	chr3:151298450-151298724	IMR90	lung:	n/a	chr3:151298600-151298611 chr3:151298600-151298611 chr3:151298575-151298592
31	CEBPB	chr3:151298477-151298699	A549	lung:	n/a	chr3:151298600-151298611 chr3:151298600-151298611 chr3:151298575-151298592
32	CEBPB	chr3:151298985-151299057	K562	blood:	n/a	n/a
33	CEBPB	chr3:151298480-151298720	K562	blood:	n/a	chr3:151298600-151298611 chr3:151298600-151298611 chr3:151298575-151298592
34	CEBPB	chr3:151361858-151362029	A549	lung:	n/a	chr3:151361932-151361945 chr3:151361932-151361945 chr3:151361932-151361943 chr3:151361932-151361945
35	CEBPB	chr3:151298386-151298792	Hela-S3	cervix:	n/a	chr3:151298600-151298611 chr3:151298600-151298611 chr3:151298575-151298592
36	CEBPB	chr3:151298413-151298731	ECC-1	luminal epithelium:	n/a	chr3:151298600-151298611 chr3:151298600-151298611 chr3:151298575-151298592
37	CEBPB	chr3:151348880-151349267	HepG2	liver:	n/a	chr3:151349066-151349077
38	CEBPB	chr3:151348880-151349238	K562	blood:	n/a	chr3:151349066-151349077
39	CEBPB	chr3:151348963-151349187	A549	lung:	n/a	chr3:151349066-151349077
40	CEBPB	chr3:151361847-151361986	K562	blood:	n/a	chr3:151361932-151361945 chr3:151361932-151361945 chr3:151361932-151361943 chr3:151361932-151361945
41	CEBPD	chr3:151348828-151349215	K562	blood:	n/a	chr3:151349065-151349076
42	CHD2	chr3:151347892-151348118	HepG2	liver:	n/a	n/a
43	CHD2	chr3:151307312-151307523	H1-hESC	embryonic stem cell:	n/a	n/a
44	CHD2	chr3:151348855-151348899	HepG2	liver:	n/a	n/a
45	CTCF	chr3:151306513-151306560	GM13976	blood:	n/a	n/a
46	CTCF	chr3:151357040-151357190	Caco-2	colon:	n/a	n/a
47	CTCF	chr3:151305684-151305785	GM10266	blood:	n/a	n/a
48	CTCF	chr3:151366226-151366464	K562	blood:	n/a	n/a
49	CTCF	chr3:151305466-151305545	GM13977	blood:	n/a	n/a
50	CTCF	chr3:151350640-151350790	HRE	kidney:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:151309377-151309427	Hepatocyte	liver:	n/a
2	chr3:151309377-151309427	MCF-7	breast:	n/a
3	chr3:151309377-151309427	HUVEC	blood vessel:	n/a
4	chr3:151309377-151309427	GM12891	blood:	n/a
5	chr3:151309377-151309427	HepG2	liver:	n/a
6	chr3:151309377-151309427	HCPEpiC	choroid plexus:	n/a
7	chr3:151309377-151309427	GM12878	blood:	n/a
8	chr3:151309377-151309427	CMK	blood:	n/a
9	chr3:151309377-151309427	U87	brain:	n/a
10	chr3:151309377-151309427	NT2-D1	testis:	n/a
11	chr3:151309377-151309427	NHBE	bronchial:	n/a
12	chr3:151309377-151309427	HPAEpiC	pulmonary alveolar:	n/a
13	chr3:151309377-151309427	ECC-1	luminal epithelium:	n/a
14	chr3:151309377-151309427	H1-hESC	embryonic stem cell:	embryo
15	chr3:151309377-151309427	PANC-1	pancreas:	n/a
16	chr3:151309377-151309427	MCF10A-Er-Src	breast:	n/a
17	chr3:151309377-151309427	HCM	heart:	n/a
18	chr3:151309377-151309427	Hela-S3	cervix:	n/a
19	chr3:151309377-151309427	AG09309	skin:	n/a
20	chr3:151309377-151309427	AG04450	lung:	fetal
21	chr3:151309377-151309427	BJ	skin:	n/a
22	chr3:151309377-151309427	AG04449	skin:	fetal
23	chr3:151309377-151309427	GM06990	blood:	n/a
24	chr3:151309377-151309427	BE2_C	brain:	n/a
25	chr3:151309377-151309427	HAEpiC	amniotic membrane:	n/a
26	chr3:151309377-151309427	HEK293	kidney:	embryo
27	chr3:151309377-151309427	AG10803	skin:	n/a
28	chr3:151309377-151309427	SK-N-SH_RA	brain:	n/a
29	chr3:151309377-151309427	SK-N-MC	brain:	n/a
30	chr3:151309377-151309427	HCF	heart:	n/a
31	chr3:151309377-151309427	PrEC	prostate:	n/a
32	chr3:151309377-151309427	HRPEpiC	eye:	n/a
33	chr3:151309377-151309427	NHDF-neo	bronchial:	n/a
34	chr3:151309377-151309427	ProgFib	skin:	n/a
35	chr3:151309377-151309427	RPTEC	kidney:	n/a
36	chr3:151309377-151309427	NB4	blood:	n/a
37	chr3:151309377-151309427	HNPCEpiC	eye:	n/a
38	chr3:151309377-151309427	HCT-116	colon:	n/a
39	chr3:151309377-151309427	SAEC	small airway:	n/a
40	chr3:151309377-151309427	HL-60	blood:	n/a
41	chr3:151309377-151309427	GM12892	blood:	n/a
42	chr3:151309377-151309427	GM19239	blood:	n/a
43	chr3:151309377-151309427	SK-N-SH	brain:	n/a
44	chr3:151309377-151309427	NH-A	brain:	n/a
45	chr3:151309377-151309427	K562	blood:	n/a
46	chr3:151309377-151309427	IMR90	lung:	fetal
47	chr3:151309377-151309427	Jurkat	blood:	n/a
48	chr3:151309377-151309427	A549	lung:	n/a
49	chr3:151309377-151309427	LNCaP	prostate:	n/a
50	chr3:151309377-151309427	T-47D	breast:	n/a

(count:34 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr3:151297378..151299096-chr3:151301123..151304068,3	K562	blood:
2	chr3:151324186..151325701-chr3:151326102..151328350,2	K562	blood:
3	chr3:151361489..151364301-chr3:151378670..151380676,2	K562	blood:
4	chr3:151320448..151323170-chr3:151323551..151325853,2	K562	blood:
5	chr3:151342162..151344399-chr3:151344926..151349175,4	K562	blood:
6	chr3:151346597..151348404-chr3:151371811..151374449,2	K562	blood:
7	chr3:151368725..151372325-chr3:151374219..151376148,3	K562	blood:
8	chr3:151341910..151344399-chr3:151344926..151348103,3	K562	blood:
9	chr3:151295351..151297607-chr3:151300115..151301880,2	K562	blood:
10	chr3:151139002..151140589-chr3:151347309..151349080,2	K562	blood:
11	chr3:151304082..151306609-chr3:151340785..151343221,2	K562	blood:
12	chr3:151304607..151306547-chr3:151313096..151315639,2	K562	blood:
13	chr3:151348816..151351046-chr3:151357034..151359240,2	MCF-7	breast:
14	chr3:151296689..151298211-chr3:151300245..151302746,2	MCF-7	breast:
15	chr3:151341910..151344399-chr3:151344926..151348103,3	K562	blood:
16	chr3:151369841..151371616-chr3:151374219..151375912,2	K562	blood:
17	chr3:151320448..151323170-chr3:151323551..151325853,2	K562	blood:
18	chr3:151359538..151361264-chr3:151361716..151364301,2	K562	blood:
19	chr3:151303163..151304744-chr3:151305743..151307789,2	K562	blood:
20	chr3:151301981..151304744-chr3:151305743..151307558,2	K562	blood:
21	chr3:151324186..151325701-chr3:151326102..151328350,2	K562	blood:
22	chr3:151296689..151298211-chr3:151300245..151302746,2	MCF-7	breast:
23	chr3:151303163..151304744-chr3:151305743..151307789,2	K562	blood:
24	chr3:151347481..151350137-chr3:151351876..151354602,2	MCF-7	breast:
25	chr3:151304082..151306609-chr3:151340785..151343221,2	K562	blood:
26	chr3:151304607..151306547-chr3:151313096..151315639,2	K562	blood:
27	chr3:151359538..151361264-chr3:151361716..151364301,2	K562	blood:
28	chr3:151342162..151344399-chr3:151344926..151349175,4	K562	blood:
29	chr3:151299413..151301641-chr3:151302443..151304307,2	K562	blood:
30	chr3:151301981..151304744-chr3:151305743..151307558,2	K562	blood:
31	chr3:151267449..151269580-chr3:151340230..151343017,2	K562	blood:
32	chr3:151297378..151299096-chr3:151301123..151304068,3	K562	blood:
33	chr3:151348816..151351046-chr3:151357034..151359240,2	MCF-7	breast:
34	chr3:151299413..151301641-chr3:151302443..151304307,2	K562	blood:

(count:4 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-IGSF10-1	chr3:151318535-151318744	XLOC_003286
2	lnc-AADACL2-2	chr3:151360495-151360663	ENSG00000241151
3	lnc-IGSF10-1	chr3:151299327-151299442	XLOC_003286
4	lnc-AADACL2-2	chr3:151354962-151355060	ENSG00000241151

No data

Variant related genes	Relation type
ENSG00000241151	TF binding region
ENSG00000222833	TF binding region
ENSG00000241151	CpG island
ENSG00000222833	CpG island
ENSG00000222833	chromatin interactions

Extended variants
information (count: 2135 )
Associated
traits (count: 54 )

Variant overlapped rSNPs/rCNVs (count:2135 , 50 per page) page: 1 2 3 4 5 6 7 ... 43

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs13080292	chr3:151298216-151298217	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs184756505	chr3:151298219-151298220	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs565799063	chr3:151298258-151298259	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs550272639	chr3:151298320-151298321	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs534717437	chr3:151298460-151298461	Weak transcription Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs144062823	chr3:151298464-151298465	Weak transcription Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs551510849	chr3:151298504-151298505	Weak transcription Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs189673619	chr3:151298510-151298511	Weak transcription Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs537382596	chr3:151298531-151298532	Weak transcription Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs144947120	chr3:151298559-151298560	Weak transcription Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs149069422	chr3:151298682-151298683	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs116288466	chr3:151298705-151298706	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs553126217	chr3:151298707-151298708	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs115300583	chr3:151298720-151298721	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs545072651	chr3:151298721-151298722	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs554180877	chr3:151298740-151298741	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs115069226	chr3:151298756-151298757	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs143331696	chr3:151298757-151298758	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs138976651	chr3:151298829-151298830	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs181316297	chr3:151298832-151298833	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs185148789	chr3:151298836-151298837	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs145903117	chr3:151298861-151298862	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs540008684	chr3:151298867-151298868	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs7650394	chr3:151298872-151298873	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs527483277	chr3:151298963-151298964	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs559892371	chr3:151299036-151299037	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs528596011	chr3:151299078-151299079	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs59192343	chr3:151299150-151299151	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs545977117	chr3:151299171-151299172	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs200864144	chr3:151299173-151299174	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs369313551	chr3:151299196-151299197	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs551842236	chr3:151299211-151299212	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs7650550	chr3:151299224-151299225	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs530887170	chr3:151299245-151299246	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs551000095	chr3:151299268-151299269	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs190078210	chr3:151299322-151299323	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs536924126	chr3:151299352-151299353	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
38	rs531607112	chr3:151299387-151299388	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
39	rs181856849	chr3:151299393-151299394	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
40	rs141841451	chr3:151299459-151299460	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs538405242	chr3:151299517-151299518	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs116782877	chr3:151299544-151299545	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs575144230	chr3:151299613-151299614	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs544158540	chr3:151299624-151299625	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs150625822	chr3:151299625-151299626	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs549541234	chr3:151299633-151299634	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs568035732	chr3:151299634-151299635	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs114866689	chr3:151299672-151299673	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs529019591	chr3:151299673-151299674	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs559955561	chr3:151299695-151299696	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:54)

Disease	PMID	Source
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Squamous cell cancer	20885788	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	22032731	CNVD
Breast cancer	16461572	CNVD
Neuroblastoma	17533364	CNVD
Cervical Cancer	21857958	CNVD
Melanoma	21693616	CNVD
Lung cancer	21426551	CNVD
Cancer	21637783	CNVD
Cervical cancer	21063398	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oral cancer	21386901	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	22065749	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Basal cell lymphoma	21115979	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Hepatocellular carcinoma	16750200	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myelodysplastic syndrome	21251322	CNVD
Blepharophimosis-ptosis-epicanthus inversus syndrome	22067867	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21364760	CNVD
Basal cell lymphoma	17170743	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Breast cancer	16608533	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	16773561	CNVD
Non-small cell lung cancer	19010865	CNVD
abnormal development	18461090	CNVD
Myelofibrosis	22110671	CNVD
Uveal melanoma	20484589	CNVD
Breast cancer	21509527	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:181 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:151295000-151302400	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
2	chr3:151295600-151302000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
3	chr3:151296600-151303400	Enhancers	Dnd41	blood
4	chr3:151297400-151298800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
5	chr3:151297400-151299200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
6	chr3:151297600-151298400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
7	chr3:151297600-151299000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
8	chr3:151297800-151298600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
9	chr3:151297800-151298600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
10	chr3:151297800-151298800	Weak transcription	NHDF-Ad	bronchial
11	chr3:151297800-151299000	Enhancers	Hela-S3	cervix
12	chr3:151297800-151299600	Enhancers	Adipose Nuclei	Adipose
13	chr3:151297800-151299600	Enhancers	Osteobl	bone
14	chr3:151298000-151298200	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
15	chr3:151298000-151298400	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
16	chr3:151298000-151298600	Enhancers	Colon Smooth Muscle	Colon
17	chr3:151298000-151299200	Enhancers	Muscle Satellite Cultured Cells	--
18	chr3:151298000-151302400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
19	chr3:151298400-151298600	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
20	chr3:151298400-151298800	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
21	chr3:151298400-151299200	Enhancers	Duodenum Smooth Muscle	Duodenum
22	chr3:151298400-151299200	Enhancers	Fetal Intestine Large	intestine
23	chr3:151298400-151299400	Enhancers	Fetal Intestine Small	intestine
24	chr3:151298600-151298800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
25	chr3:151298600-151302400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
26	chr3:151298600-151302400	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
27	chr3:151298800-151299000	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
28	chr3:151298800-151299000	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
29	chr3:151298800-151299200	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
30	chr3:151298800-151299400	Enhancers	NHDF-Ad	bronchial
31	chr3:151299000-151299200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
32	chr3:151299000-151299400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
33	chr3:151299000-151302200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
34	chr3:151299200-151299400	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
35	chr3:151299200-151299600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
36	chr3:151299400-151299600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
37	chr3:151299400-151307000	Weak transcription	NHDF-Ad	bronchial
38	chr3:151302000-151302600	Enhancers	iPS-18 Cell Line	embryonic stem cell
39	chr3:151302000-151303000	Enhancers	Primary hematopoietic stem cells short term culture	blood
40	chr3:151302200-151302800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
41	chr3:151302400-151302800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
42	chr3:151302400-151302800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
43	chr3:151302400-151302800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
44	chr3:151302400-151302800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
45	chr3:151302400-151303000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
46	chr3:151306000-151307000	Weak transcription	iPS-20b Cell Line	embryonic stem cell
47	chr3:151306600-151307600	Enhancers	HUES48 Cell Line	embryonic stem cell
48	chr3:151307000-151307400	Enhancers	NHDF-Ad	bronchial
49	chr3:151307000-151307600	Enhancers	iPS-20b Cell Line	embryonic stem cell
50	chr3:151307000-151307600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links